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~ Ident i f icat ion of  Pat lanta With Improvement  o f  LVEF 
and Heart Failure 8ymptome by Combined Low.High 
DoN Dobutomlno E©hocardlogrnphy 
J.J, B~x, J.H, Cornel ~ . D, Potdern~rln~l ,A, Elheady;', E, Ooorsma;', 
P,M, Florotti :f, Leiden, The Netttorl~nds: 'Atknmar, Tltu N~thod~md~: 
"~ Rotto~m, The Nothorl~lnd~ ; " Udino, Italy 
Oobut~mine stress.echo (DSE, combined low, ~nd high-dose) cnn be used to 
pre~llct improvement ot LVEF niter rovosculatlz~tlon, tt is unknown whether 
the technique can also Identlly patients who may Improve in heart faduro 
(HF) symptoms, We evaluated the u~e oi DSE to identify patients with 
improvement of LVEF and HF symptoms alter rovaseulnnzatlen, Patients 
(n ,~ 62) with chronic coronary adory dtseaso and LVEF .: 35% underwent 
DSE (16-segment model) before rovascularlzatlon, Criteria for viability were 
a blph0,sl¢ response, sustained improvement or worsening of wall motion 
during DSE, LVEF was assessed by radionucllde ventrculography before 
and 3 months alter revnscularl;tatlon Improvement ot LVEF was delined by 
an increase of LVEF by ::5%, HF functional class was assessed bolero and 3 
months alter revascularlzatlon, Twenty-one patients lmprevod ~:5% In LVEF 
alter the rovasculanzation (26 t 7% versus 34 ~ 7%) while 41 remained 
unchanged (29 * 5% versus 28 :t 5%), The patients with an improvement 
of LVEF ~:5% e~hibited significantly more viable segments on DSE (5.5 
2.2 versus 1,7 ~ 1.4, P - 0,01), Twenty-two patients (group l) had :4  viable 
segments on OSE, wl~ile 40 had • 4 viable segments (group II), In group I 
the LVEF increased from 27 t 6% to 33 I 7% (P.  0,05) and the HF class 
decreased (2.5 t 09  vs 1.6 t 06, P • 005). In group II LVEF (29 :t 5°0 vs 
28 i 6%, NS) nor HF functional class (2.5 ~ 0,5 vs 2,6 t 0.0, NS) improved. 
In conclusion, substantial viability on DSE helps to identify patients who may 
improve In LVEF ~nd HF symptoms after rovascularization. 
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~ Nlsoldiplne Echocardlography: A New Method for  
Assessing Myocardial Viability Alter Acute 
Myocardial Infarction Treated With Thrombolysls 
S, Rosanio, I, Shoiban, S, Tonni, M, Toechi, A. Anzuini, G. Rosano, 
P Pagnotia, M Mentodano. S, Chierehia. H.$.R.. M#an: University of 
Verona. Verona. Italy: U,'£M,B., Galveston. TX, USA 
Background: Previous clinical studies h~ve shown that the i,v, admmistratton 
ot nisoldipine (Nis), a highly specific dihydropyridtne calcium antagonist, can 
recruit an inotropic reserve in stunned myocardium Mechanisms of improved 
contractility may include increase in coronary blood flow, LV alterload reduc- 
tion and improved myocyte calcium handling. However. the potential value 
et Nis echocardiography (Nis-E) in detecting myocardial viability after acute 
myocardial infarction (AMI) has never been tested. 
Methods: In this study. 30 consecutive pts (age 55 :t 8 yrs; 19 m) under- 
went Nis-E end rest - 4 h redistribution Thallium-201 SPECT (TI) at 8 ~. 2 
days after uncomplicatect hrembolyzed AMI (17 anterior site). A 16-segment 
4-grade score model was used tor ~nalysis of both Nis-E and TI. Nis was 
given Lv, in a dose of 3 mcg/kg over 5 min and 2D echocardiograms were 
continuously obtained and intermittentiy recorded during and up to 20 rain 
alter drug administration. Viability was defined as wall motion score improve- 
ment during Nis-E -1 grade or as Thallium uptake :60% at rest or upon 
redistribution. 
Resu;ts: Nis-E was completed in all pts without signilicant side effects or 
development of echo Or ECG signs of ischem~a. Overall 89 basally asyn- 
ergic segments were scored. Nis-E and TI had concordant results in 26/31 
(84%) TI-viablo segments and 55/58 (95°/,,) TI-nonviable segments, When 
comparod with quantitative TI uptako analysis, the same NIs.E.viablo or 
• nonvleblo segments sltowed an avomgo % TI activity o! 75 :t 7% and 39 
10%, mspoctlvaly (p ,~ 0,01), At follow-up (4,5 :t 1,5 months) rest echo, 23 
o! 26 Nls.E.vlable and 9 ol 55 NIs.E-nonviablo segments had a functional 
mceven/(88% vs 16%; p • 0,01), 
Conclusions: NIs.E in the early post.AMI period is a safe, oltectivo a~l 
relatively inexpensive method let assossing myocardial viability: 
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~ l 'he  Impact of 8ubendocardlal 8carting on 
Prodi©tlon of Improvement of Rsglonal Wall Motion 
Alter Ravaecularl,atlen by Dobutamlne 
Echo©ardlography 
J,J, BOIX, JH, Cornel I , A, Elhondy ~, O, Poldorm~ns ~, P,M, FioraltP, 
J,R,T,C, RoolandP', L~idon, Tho NoflvorhmoL~: t AIkm~l(Ir, The N~fhe~l~nd~; 
~'Roffo~d~m, The Nethed~nds; 'rUdlno, It~ly 
The amount el 5car i5 [ol~tQd to the seventy el the testing w~,ll met=on ~b, 
norm~lw: mild dy~synorgy is !roqgently ebson/od in 5~_I-rl'~ndoc~]t~ial ,~ r~, 
while severe dysSynetgy occur~ in tr~nsmu[~l sc~r~. We ccJmp~t~ rh~ ~,e- 
carney el low-dose debut~mino echo to predict improvement el tunction ,~lter 
rov~l_seulari;tation (REV) in ~ovorely versus mildly dys,~yner~i¢ my~:;~lium 
Patients (n - 91) wllh chronic, i~chemic LV dysfunction who were ~hod- 
uled ler REV were mcludod~ All underwent Iow.Uoso dobutsmino (5 ~r 10 
~glrg/mint eehoc~rdtogr~]phy before the REV, Contractile me.errs dune 9 !ow- 
do~o dobutamino infusion was considered indicative tot fanctlona~ r~ovefy. 
Improvement el function after the REV was assessed by resting e~hocar. 
diogrophy bolero and 3 months a~or REV. 622 segments were dyswnorgic 
(263 mild dyssynorgie, 359 severe dyssynerg¢). Contractile reserve was 
pro~enf in 191 (73%) el the mildly dyssynorgie segments and in 138 (38%) 
o! tire severely dyssynergic 3egments, Recoven/of function occurr~J dn 84 
(32%) mildly dyssynergio segments and in 89 (25%) severely dyswnergic 
segments. The sensitivities ol dobutamine echo were 96% and 89% iNS) in 
mildly and severely dyssynorg~c segments, while the specilicities were 39% 
and 7B% respectively (P - 0,05). The sl~il ieity dn mildly hypokinetic see, 
meals was also lower in patients with non-Q wave infamtion versus patients 
with a Q wave (29% versus 40%). Thus, specificity was significantly lower 
in mildly dyssynergic segments, suggesting overestimation of recover/and 
appears to be related to the presence of subendecardial scar. 
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~823-1 I Inc reased  Circulat ing Soluble Fas In Pat ients With 
Di lated Cardlomyopathy 
Y. Shigematsu, H. Kawakami, 1". Ohtsuka, H. Okayama, Y. Hayashi, Y. Hare. 
K. Kodama, M Hamada, P. Qu, K. HLwada. Ehime UniverSity, Ehime. Japan 
Background: Apoptosis in myocyte has been demonstrated. However, wheth- 
er this form of myocyte death occurs in the tailing human head is not com- 
pletely understood. In this study, we assessed plasma soluble Fas (sFas) as 
an index of Fas-Fas Ligand system activation and the presence of apoptosis 
in dilated cardiomyopathy. 
Mehod$: sFas was measured by enzyme-linked immunosorbent assay. 
Plasma sFas levels were measured in 33 patients with dilated cardiomvepa- 
thy (DCM) and 1'2 age-matched normal controls iNCl. 
Results: Plasma sFas levels in patients with DCM were significantly higher 
than those in NC (2.42 : 1.02 vs 1,66 ± 0.20 ng/ml, p = 0.015). Patients with 
DCM were divided into two groups according to plasma sFas. Group I (n = 
15): plasma sFas levels were less than the mean value + 2SD in NC. Group 
II (n = 18): plasma sFas levels were higher than the mean value + 2S r') in 
NC. 
sFas fngJml) LVDd (mm) LVDs (mm) FS t°o) 
Group I 1,68 ± 0.18 694 t 7 5 57.4 ~ 8.4 17.6 ,.., 4,7 
Group II ~.00 ~ 058" 70.0 .* 7.1 59 4 L 9.2 148 t 73 
These values are mean ~_ SD, LVDd = left yen!titular arid-alias!cite Uimension. LVDs = left 
ventrtcutar end-systolic dimension. FS = tractqonal shortening, "p . 0.00Of vs el'cup L 
There were 5 deaths for worsening heart failure in group II, but there was 
no death in group I during follow-up period (34 ± 11 months). In addition, 
there was a good positive relation between plasma sFa~ levels and New York 
Heart Association (NYHA) functional class (r = 0.76, p < 0.0001 ) in patients 
with DCM. 
